Free Republic

A Harvard University-affiliated teaching hospital is seeking to retract or correct dozens of papers authored by four of its top researchers — including the hospital’s CEO — following a probe into allegations of data falsification. The Dana-Farber Cancer Institute in Boston has already initiated six retractions to papers and 31 others are in the process of being corrected, the hospital’s research integrity officer, Dr. Barrett Rollins, confirmed to the Harvard Crimson. The corrections follow claims of data falsification leveled against the cancer institute’s CEO, Dr. Laurie Glimcher, chief operating officer Dr. William Hahn, director of the Clinical Investigator Research Program...

...Which brings us to the politically motivated attack on FDA Deputy Commissioner Scott Gottlieb -- one of the fellow forward thinkers Dr. Eschenbach will find at the agency. In its zeal to find more "cronyism" in the Bush Administration, Time fingered Dr. Gottlieb this week without offering any evidence of any special connections to the White House -- family or otherwise. Time seems bothered that Dr. Gottlieb is young and recently worked in the private sector part-time as editor of a medical technology newsletter. Largely ignored by Time is Dr. Gottlieb's previous experience in a substantial policy-making FDA role under...